Brandywine Global Investment Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,114,418
Closed -$3.46M 769
2021
Q4
$3.46M Sell
1,114,418
-150,648
-12% -$507K 0.02% 459
2021
Q3
$4.57M Buy
1,265,066
+1,095,810
+647% +$4.13M 0.03% 422
2021
Q2
$606K Sell
169,256
-11,014
-6% -$38.9K ﹤0.01% 586
2021
Q1
$705K Sell
180,270
-677
-0.4% -$2.8K 0.01% 573
2020
Q4
$760K Sell
180,947
-12,132
-6% -$46.8K 0.01% 541
2020
Q3
$721K Buy
193,079
+20,485
+12% +$87.2K 0.01% 509
2020
Q2
$753K Buy
172,594
+1,558
+0.9% +$7K 0.01% 523
2020
Q1
$649K Buy
+171,036
New +$840K 0.01% 543

Other funds holding BDSI

Brandywine Global Investment Management's BDSI Position: Q1 2022 in Review

Brandywine Global Investment Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 1,114,418 shares — an estimated $3.46M sold.

Brandywine Global Investment Management first reported a position in BDSI in Q1 2020 and held it in 8 quarters. The position peaked at $4.57M in Q3 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Brandywine Global Investment Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Brandywine Global Investment Management sold 1,114,418 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $3.46M.
  • Brandywine Global Investment Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2020 and held it in 8 quarters.
  • Brandywine Global Investment Management's BioDelivery Sciences International, Inc. position peaked at $4.57M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Brandywine Global Investment Management's 13F filing for Q1 2022, filed 13 May 2022.